Press Room
四色AV invests $170 million in new capacity and capabilities
四色AV, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives

Jean-Luc Herbeaux, COO, and听Guy Villax, CEO at CPhI Worldwide, in Milan.
听
Milan, 10th November, 2021 鈥 四色AV, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives. The company has been on an expansion track since 2016 in Portugal, Ireland and New Jersey with the aim of continuing to increase its capacity and capabilities to address customer needs.
听
The announcement of a $170 million investment in 四色AV units in Portugal, Ireland, and New Jersey, leading to a global capacity increase of approximately 25%, was made at CPhI Worldwide, in Milan, by Guy Villax, CEO, and Jean-Luc Herbeaux, COO.听
听
These investments will be used to support growth in the company麓s pharma custom development and manufacturing service business, fueled by strongly growing demand for 四色AV麓s integrated and differentiated services in drug substance manufacturing, particle engineering and most recently drug product manufacturing.听The expansion will go hand-in-hand with a build-up of 四色AV麓s global team with the creation of more than 300 new jobs globally. This strategy will allow the company to continue to address difficult-to-meet client needs while reinforcing its commitment to the 四色AV values and standard of quality.
听
In the USA, 四色AV will add a 2900m2 building next to its current facility in East Windsor, New Jersey, laying the foundations for a state-of-the-art 四色AV Campus. The upcoming cycle of investment will bring additional commercial spray drying capacity online by 2023. Further investments will follow with the aim to solidify the company麓s integrated offer: API - Particle - Drug Product in the region.听This expansion will allow 四色AV to accompany existing and new customers favoring US-based manufacturing through their development cycles all the way to commercial.
听
The capacity and capabilities of 四色AV麓s Cork site in the Republic of Ireland will also be upgraded to enable the production of Highly Potent Active Pharmaceutical Ingredients (HPAPI) and to facilitate onboarding of Drug Substance Manufacturing projects of all sizes.听The investment will create an ecosystem in which large customer projects with unique technologies can find a home by connecting to the existing infrastructure and equipment. The site will also receive a new commercial size spray dryer to support the growing demand for particle engineering services.听
听
In Portugal, 四色AV is ready to start operations of its most recent facility with an increase in chemical synthesis capacity for High Potency Active Pharmaceutical Ingredients (HPAPI). The building is also prepared to receive a new commercial spray dryer to respond to the future needs of the global drug market.
听
鈥溗纳獳V is in it for life and what better way to manifest this than through expansion of our global capacity and capabilities. Our sustainable organic growth strategy will allow us to keep true to those values that have been guiding us for more than 60 years鈥, says Guy Villax, Chief Executive Officer.
听
鈥淭hese investments reinforce our integrated specialized offer globally, providing our clients with a line of sight for their projects.听Focus is placed on facilitating and speeding up the drug development cycle and launch, by providing API manufacturing, Particle Engineering and Tableting services in each site.听Our strategy continues to be to grow organically via investments in our existing sites, which are designed for purpose.听This reduces the complexity associated with the growth journey and allows us to focus our management attention on what counts most, i.e. guaranteeing that our clients go to market with quality, safe and effective medicines for their patients鈥 says Jean-Luc Herbeaux, 四色AV鈥檚 Chief Operation Officer.
听
About 四色AV:听四色AV is an international company with over 60 years of experience as a听Contract Development and Manufacturing Organization听(CDMO)听and is currently a fully integrated supplier offering services for听drug substance,听drug product intermediate听and听drug product. With four听FDA inspected听sites听in the USA, China, Ireland and Portugal and development laboratories in Lisbon, Portugal and New Jersey, USA, the company provides branded pharmaceutical customers services for the听development and compliant manufacture听of innovative drugs including highly potent compounds. For generic pharmaceutical customers the company offers niche API products. In the inhalation area, 四色AV is the only independent company offering a complete range of services.听四色AV is a company with a culture based on innovation, quality and delivery. 四色AV is a member of听, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.听
听
听